Importance of Delayed Reperfusions in Patients With Incomplete Thrombectomy.

"Disclosures Dr Meinel reports research support from the Bangerter Rhyner Foundation, Swiss National Science Foundation (SNSF), and the Swiss Heart Foundation. Dr Heldner reports research support from Swiss Institute for Translational and Entrepreneurial Medicine (SITEM) Research Funds‚ Swiss Heart Foundation, and SNSF. Dr Mordasini reports research support from Siemens, Cerenovus, iSchemaview, Medtronic, and Stryker, and is receipt of honoraria and consultation fees from Medtronic, Cerenovus, Phenox, and Microvention. Dr Arnold reports personal fees from Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Covidien, Daiichi Sankyo, Novartis, Sanofi, Pfizer, Medtronic. Dr Gralla is a global principal investigator of the SWIFT DIRECT study (Solitaire With the Intention for Thrombectomy Plus Intravenous Tissue Plasminogen Activator Versus DIRECT Solitaire Stent-Retriever Thrombectomy in Acute Anterior Circulation Stroke; Medtronic), therefore consultant for Medtronic, and receives SNSF grants for magnetic resonance imaging in stroke. Dr Fischer reports grants during the conduct of the study from Medtronic, Stryker, and CSL Behring. Dr Kaesmacher reports grants from the Swiss Academy of Medical Sciences/Bangerter Foundation, Swiss Stroke Society, Clinical Trials Unit Bern/Inselspital Bern, and the SNSF during the conduct of the study. The other authors report no conflicts."

"Sources of Funding None."